tiprankstipranks
Trending News
More News >
Inhibikase Therapeutics (IKT)
NASDAQ:IKT

Compare Inhibikase Therapeutics (IKT) vs. Competitors

Compare
176 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Inhibikase Therapeutics
$1.65
$206.15M
-2.89
-39.56%
4 Buy
0 Hold
0 Sell
Strong Buy
Atossa Therapeutics
$0.60
$77.76M
-2.47
-33.26%
4 Buy
0 Hold
0 Sell
Strong Buy
Anixa Biosciences
$3.16
$110.48M
-9.56
41.23%
1 Buy
0 Hold
0 Sell
Moderate Buy
Spero Therapeutics
$2.40
$141.41M
167.56%
0 Buy
2 Hold
0 Sell
Hold
Surrozen
$20.00
$171.43M
-0.92
68.78%
3 Buy
0 Hold
0 Sell
Strong Buy
TScan Therapeutics
$1.20
$68.10M
-1.02
-56.98%
5 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IKT
Inhibikase Therapeutics
1.65
-1.11
-40.22%
ATOS
Atossa Therapeutics
0.58
-0.27
-31.76%
ANIX
Anixa Biosciences
3.22
0.64
24.81%
SPRO
Spero Therapeutics
2.40
1.57
189.16%
SRZN
Surrozen
20.00
8.15
68.78%
TCRX
TScan Therapeutics
1.14
-1.32
-53.66%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts